What is it about?
• This study aimed to investigate the potential of peptides derived from quinoa seed proteins as multi-target antagonists against SARS-CoV-2, which is a virus that causes severe acute respiratory syndrome. • The seven identified peptides were predicted to interact with key binding residues and catalytic residues on three viral targets: spike glycoprotein receptor domain, main protease (M pro) and papain like protease (PL pro). • These interactions could potentially block entry of the virus into host cells and suppress its replication.
Featured Image
Photo by Glen Carrie on Unsplash
Why is it important?
It is important to identify potential peptides that can act as multi-target antagonists against SARS-CoV-2, since this virus has caused a global pandemic. The seven identified peptides could potentially be used in drug discovery and development for the treatment of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2).
Read the Original
This page is a summary of: In Silico Identification of Multi-target Anti-SARS-CoV-2 Peptides from Quinoa Seed Proteins, International Journal of Peptide Research and Therapeutics, April 2021, Springer Science + Business Media,
DOI: 10.1007/s10989-021-10214-y.
You can read the full text:
Contributors
The following have contributed to this page
